On a 5-year-old girl with multiple sclerosis treated with natalizumab.

Autor: Sotgiu S; Unit of Child Neuropsychiatry, Department of Medicine, Surgery and Pharmacy, University Hospital of Sassari, University of Sassari, Viale San Pietro 42, 07100, Sassari, Italy. stefanos@uniss.it., Nieddu A; Unit of Child Neuropsychiatry, Department of Medicine, Surgery and Pharmacy, University Hospital of Sassari, University of Sassari, Viale San Pietro 42, 07100, Sassari, Italy., Pruna D; Pediatric Neurology and Epileptology Unit, Pediatric Department, ARNAS Brotzu, Cagliari, Italy., Madrau A; Unit of Child Neuropsychiatry, Department of Medicine, Surgery and Pharmacy, University Hospital of Sassari, University of Sassari, Viale San Pietro 42, 07100, Sassari, Italy., Zarbo IR; Multiple Sclerosis Centre, Department of Medicine, Surgery and Pharmacy, University Hospital of Sassari, Sassari, Italy., Carta A; Unit of Child Neuropsychiatry, Department of Medicine, Surgery and Pharmacy, University Hospital of Sassari, University of Sassari, Viale San Pietro 42, 07100, Sassari, Italy.
Jazyk: angličtina
Zdroj: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2023 Aug; Vol. 44 (8), pp. 2963-2965. Date of Electronic Publication: 2023 Mar 29.
DOI: 10.1007/s10072-023-06780-2
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje